BRIEF published on 12/15/2025 at 07:35, 11 months 5 days ago Appointment of François Michel as CEO of GTT Group Board Of Directors Technological Innovation Chief Executive Officer GTT Group François Michel
BRIEF published on 12/15/2025 at 07:35, 11 months 5 days ago Nomination de François Michel au poste de PDG du groupe GTT Innovation Technologique Conseil D'administration Directeur Général François Michel Groupe GTT
BRIEF published on 12/15/2025 at 07:35, 11 months 5 days ago Nomination de François Michel à la tête du groupe GTT Stratégie Innovation Nomination GTT François Michel
BRIEF published on 12/15/2025 at 07:35, 11 months 5 days ago François Michel appointed head of the GTT group Innovation Appointment Strategy GTT François Michel
BRIEF published on 12/15/2025 at 07:10, 11 months 5 days ago Piramal Pharma Solutions Achieves High Net Promoter Score Operational Excellence Net Promoter Score Customer Loyalty Piramal Pharma Competitive Positioning
BRIEF published on 12/15/2025 at 07:10, 11 months 5 days ago Piramal Pharma Solutions obtient un score de recommandation client élevé Excellence Opérationnelle Fidélité Client Piramal Pharma Score Net De Promoteur Positionnement Concurrentiel
BRIEF published on 12/15/2025 at 07:10, 11 months 5 days ago Sanofi Halts Pursuit of Regulatory Registration for Tolebrutinib in PPMS Multiple Sclerosis Tolebrutinib PPMS Trial PERSEUS Study Sanofi R&D
BRIEF published on 12/15/2025 at 07:10, 11 months 5 days ago Sanofi renonce à l'autorisation de mise sur le marché du tolebrutinib dans le traitement de la SEP progressive primaire Sclérose En Plaques Tolebrutinib Essai PPMS Étude PERSEUS Recherche Et Développement Chez Sanofi
BRIEF published on 12/15/2025 at 07:10, 11 months 5 days ago Sanofi : résultats de l'étude PERSEUS sur le tolébrutinib décevants Sclérose En Plaques Sanofi Tolebrutinib Étude PERSEUS Résultats D'étude
BRIEF published on 12/15/2025 at 07:10, 11 months 5 days ago Sanofi: PERSEUS study results on tolebrutinib disappointing Study Results Multiple Sclerosis Sanofi Tolebrutinib PERSEUS Study
Published on 11/20/2026 at 02:00, 11 hours 27 minutes ago PPX Mining Announces Completion of Debt Settlement
Published on 11/19/2026 at 23:30, 13 hours 57 minutes ago EQ Inc. Reports Third Quarter 2026 Financial Results
Published on 11/19/2026 at 23:00, 14 hours 27 minutes ago Redwood AI Reports Positive Interim Q-SAFE Findings Supporting Quantum-Assisted Chemical Safety Screening
Published on 11/19/2026 at 22:35, 14 hours 52 minutes ago Pampa Medina Drilling Intersects 102m of 1.0% Cu and 5.1g/t Ag from SPRD-21; 22m of 2.1% Cu and 10g/t Ag from SPRD-18; and 8m of 3.21% Cu and 27.5g/t Ag from SPRD-24
Published on 11/19/2026 at 22:25, 15 hours 2 minutes ago Kidoz Reports Record Nine-Month Revenue of US$9,900,750
Published on 11/20/2026 at 13:01, 26 minutes ago Original-Research: Deutsche Rohstoff AG (von First Berlin Equity Research GmbH): Buy
Published on 11/20/2026 at 12:45, 42 minutes ago Hong Kong showcases its unique advantages, forges closer ties with regional economies during APEC China 2026
Published on 11/20/2026 at 12:30, 57 minutes ago Original-Research: Almonty Industries Inc (von GBC AG): BUY
Published on 11/20/2026 at 12:30, 57 minutes ago HKSTP Debuts at MEDICA 2026, Forging Hong Kong-Europe Pathways for Life and Health Tech
Published on 11/20/2026 at 11:29, 1 hour 58 minutes ago REPLOID implements 15-for-1 stock split and moves from auction to continuous trading
Published on 11/19/2026 at 19:00, 18 hours 27 minutes ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR
Published on 11/19/2026 at 19:00, 18 hours 27 minutes ago MR.BRICOLAGE : PERSPECTIVES POUR L'EXERCICE 2026
Published on 11/19/2026 at 08:30, 1 day 4 hours ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing
Published on 11/19/2026 at 08:30, 1 day 4 hours ago Souveraineté des données : Cegedim ouvre EB6, un datacenter nouvelle génération pour l'IA et la haute densité